Clinical stage pharmaceutical development Company Algernon Pharmaceuticals Inc. (CSE: AGN, OTCQB: BTHCF, Forum) announced on Thursday that leading global expert and clinician in the area of chronic liver disease, Dr. Arun Sanyal, has joined its Medical and Scientific Advisory Board.
For more on Dr. Sanyal, click here.
The Company recently deepened its researchon a promising compound, based on positive preliminary data from its first idiopathic pulmonary fibrosis study, expanding its research program.
FULL DISCLOSURE: Algernon Pharmaceuticals Inc. is a client of Stockhouse Publishing.